Τreatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer
NCT04247035 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2021-02-10
Summary
• To capture the treatment patterns and clinical characteristics of patients with ER/PR positive, HER2-negative MBC in Greece
Conditions
Sponsors & Collaborators
-
Hellenic Society of Medical Oncology
lead OTHER
Principal Investigators
-
Ioannis Boukovinas, Dr /Phd · HeSMO
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-31
- Primary Completion
- 2022-01-31
- Completion
- 2024-01-31
Countries
- Greece
Study Locations
More Related Trials
-
MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC
NCT03881605 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)
NCT01924351 ·Status: WITHDRAWN ·Phase: PHASE2
-
Patterns of Care in Hormone-receptor Positive, Advanced Breast Cancer
NCT01277926 ·Status: TERMINATED
-
Discordant HER2/Neu Status of Breast Cancer.
NCT01935739 ·Status: COMPLETED
-
Omission of Radiation in Patients With Her-2 Positive Breast Cancer
NCT03460067 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
HER2-positive Breast Cancer Registry
NCT06603597 ·Status: RECRUITING
-
Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic Syndrome
NCT06261918 ·Status: RECRUITING
-
Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes
NCT04403984 ·Status: UNKNOWN
-
Study on Clinical Features and Outcomes of Breast Sarcoma
NCT04749446 ·Status: RECRUITING
-
Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy
NCT02271828 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer
NCT03617341 ·Status: UNKNOWN
-
Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer
NCT01282931 ·Status: COMPLETED
-
A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
NCT05939128 ·Status: ACTIVE_NOT_RECRUITING
-
"Observational, Retrospective and Prospective, Non-interventional, Multicentre on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"
NCT06871501 ·Status: NOT_YET_RECRUITING
-
Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer
NCT07179744 ·Status: RECRUITING
-
Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer
NCT06358625 ·Status: RECRUITING
-
Tumour Registry Breast Cancer
NCT01351584 ·Status: COMPLETED
-
Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
NCT04683770 ·Status: UNKNOWN
-
Additional Prognostic Value of Tumor Grade Beyond the 21-gene Recurrence Score
NCT07093775 ·Status: NOT_YET_RECRUITING
-
Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer
NCT06387173 ·Status: ACTIVE_NOT_RECRUITING
-
Praegnant Breast Cancer: Early/Advanced/Metastatic
NCT02338167 ·Status: RECRUITING
-
Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
NCT07217990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Male Breast Cancer: Understanding the Biology for Improved Patient Care
NCT01101425 ·Status: ACTIVE_NOT_RECRUITING
-
Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy
NCT05866458 ·Status: RECRUITING
-
Adjuvant Treatment in Premenopausal Breast Cancer
NCT06807749 ·Status: NOT_YET_RECRUITING